2022
DOI: 10.1016/j.cegh.2022.101000
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the cost of unused medications in a hospital in Ethiopia: A cross-sectional study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 13 publications
(17 reference statements)
0
1
0
Order By: Relevance
“…Recently, public-private issues, such as donations and possible recirculation [4], including reassignment between public health utilities, in [5] have been screened in this research field. Improvements in MRLSs involving a wide range of stakeholders [6,7], and efforts to calculate the financial value of generated waste are also targets of investigation [8,9], although with limitations related to specific legal regulations and scales. With the supply chain disruptions triggered by diverse causes, such as high costs to final consumers and to government procurement [4], scholars have resurrected the debate on medicine returns not only for proper disposal (in the case of a damaged or expired product), but for possible reuse [10][11][12][13][14][15][16], regardless of the traditional argument about the likely risks entailed in a further harnessing of these products [6,11,12,15].…”
Section: Introductionmentioning
confidence: 99%
“…Recently, public-private issues, such as donations and possible recirculation [4], including reassignment between public health utilities, in [5] have been screened in this research field. Improvements in MRLSs involving a wide range of stakeholders [6,7], and efforts to calculate the financial value of generated waste are also targets of investigation [8,9], although with limitations related to specific legal regulations and scales. With the supply chain disruptions triggered by diverse causes, such as high costs to final consumers and to government procurement [4], scholars have resurrected the debate on medicine returns not only for proper disposal (in the case of a damaged or expired product), but for possible reuse [10][11][12][13][14][15][16], regardless of the traditional argument about the likely risks entailed in a further harnessing of these products [6,11,12,15].…”
Section: Introductionmentioning
confidence: 99%